# Ameriprise Financial Inc: overview

AMP · NYSE · CIK 820027 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amp.md) · [Financials](/companies/amp/financials.md) · [Filings](/companies/amp/filings.md) · [Insiders](/companies/amp/insiders.md)

Latest reported revenue: [$5.19bn](/filings/0000820027-26-000054.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 30, 2026 (XBRL us-gaap:Revenues, accession 0000820027-26-000054).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,649 d](/filings/0000820027-26-000016.md) | [4,481](/filings/0000820027-26-000027.md) | [4,490](/filings/0000820027-26-000043.md) | [4,893](/filings/0000820027-26-000054.md) | [5,047 d](/filings/0000820027-26-000016.md) | [4,886](/filings/0000820027-26-000027.md) | [5,013](/filings/0000820027-26-000043.md) | [5,191](/filings/0000820027-26-000054.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [23.0% d](/filings/0000820027-26-000016.md) | [13.0%](/filings/0000820027-26-000027.md) | [23.6%](/filings/0000820027-26-000043.md) | [18.6%](/filings/0000820027-26-000054.md) | [20.0% d](/filings/0000820027-26-000016.md) | [18.7%](/filings/0000820027-26-000027.md) | [22.2%](/filings/0000820027-26-000043.md) | [21.7%](/filings/0000820027-26-000054.md) |
| Diluted EPS | $ per share | not reported | [5.83](/filings/0000820027-26-000027.md) | [10.73](/filings/0000820027-26-000043.md) | [9.33](/filings/0000820027-26-000054.md) | not reported | [9.68](/filings/0000820027-26-000027.md) | [11.98](/filings/0000820027-26-000043.md) | [12.32](/filings/0000820027-26-000054.md) |
| Free cash flow | $m | [325 d](/filings/0000820027-26-000016.md) | [1,650](/filings/0000820027-26-000027.md) | [1,726 d](/filings/0000820027-26-000043.md) | [2,160 d](/filings/0000820027-26-000054.md) | [2,625 d](/filings/0000820027-26-000016.md) | [430](/filings/0000820027-26-000027.md) | [2,849 d](/filings/0000820027-26-000043.md) | [1,429 d](/filings/0000820027-26-000054.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.4](/filings/0000820027-24-000015.md) | [14.3](/filings/0000820027-25-000013.md) | [16.1](/filings/0000820027-26-000016.md) | [17.9](/filings/0000820027-26-000016.md) | [18.9](/filings/0000820027-26-000016.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [25.5%](/filings/0000820027-24-000015.md) | [22.0%](/filings/0000820027-25-000013.md) | [15.9%](/filings/0000820027-26-000016.md) | [19.0%](/filings/0000820027-26-000016.md) | [18.8%](/filings/0000820027-26-000016.md) |
| Diluted EPS | $ per share | [28.48](/filings/0000820027-24-000015.md) | [27.70](/filings/0000820027-25-000013.md) | [23.71](/filings/0000820027-26-000016.md) | [33.05](/filings/0000820027-26-000016.md) | [36.28](/filings/0000820027-26-000016.md) |
| Free cash flow | $bn | [3.2](/filings/0000820027-24-000015.md) | [4.2](/filings/0000820027-25-000013.md) | [4.5](/filings/0000820027-26-000016.md) | [6.4](/filings/0000820027-26-000016.md) | [8.2](/filings/0000820027-26-000016.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amp/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.64bn | 7,935,137 |  | Reduced −690,810 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.71bn | 5,900,661 |  | Reduced −31,390 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.37bn | 5,176,700 |  | Reduced −77,497 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.14bn | 4,672,743 |  | Added +80,156 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.26bn | 2,756,276 |  | Reduced −117,395 |
| [Aristotle Capital Management, LLC](/funds/860644.md) | 2026-06-30 | $955.8m | 2,083,285 |  | Reduced −128,392 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $800.0m | 1,743,842 |  | Reduced −265,899 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $753.8m | 1,643,021 |  | Added +183,271 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $683.9m | 1,490,792 |  | Reduced −8,288 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $607.5m | 1,324,189 |  | Reduced −151,145 |

## Recent filings

[All 2,969 filings](/companies/amp/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 14:04 ET | [10-Q](/filings/0000820027-26-000054.md) | Quarterly report, period 2026-09-30 | 0000820027-26-000054 |
| 2026-10-29 | 08:17 ET | [8-K](/filings/0000820027-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000820027-26-000050 |
| 2026-08-04 | 15:01 ET | [10-Q](/filings/0000820027-26-000043.md) | Quarterly report, period 2026-06-30 | 0000820027-26-000043 |
| 2026-07-23 | 07:46 ET | [8-K](/filings/0000820027-26-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000820027-26-000038 |
| 2026-06-09 | 14:09 ET | [8-K](/filings/0001104659-26-071727.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071727 |
| 2026-05-20 | 16:05 ET | [8-K](/filings/0001104659-26-064493.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064493 |
| 2026-05-07 | 15:39 ET | [10-Q](/filings/0000820027-26-000027.md) | Quarterly report, period 2026-03-31 | 0000820027-26-000027 |
| 2026-04-30 | 16:12 ET | [8-K](/filings/0001104659-26-052928.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-052928 |
| 2026-04-23 | 16:17 ET | [8-K](/filings/0000820027-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000820027-26-000020 |
| 2026-03-20 | 16:15 ET | [DEF 14A](/filings/0001104659-26-032725.md) | Proxy statement, period 2026-04-29 | 0001104659-26-032725 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000820027-26-000011.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/c9d1e04e-e5ea-47ce-87fe-f7a14f3f63b6)

## About the filer

- CIK: 820027
- Tickers: AMP
- Exchange: NYSE
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 16:03 ET. No prices; not investment advice.